ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Intangible Asset, Goodwill and Other [Abstract] |
|
| Schedule of Business Acquisitions |
The preliminary fair values of the assets and liabilities assumed in connection with the acquisition of Intelerad are as follows. | | | | | | | Preliminary allocation | Receivables | $ | 39 | | Contract assets | 27 | | | | Property, plant, and equipment | 9 | | Goodwill | 1,629 | | Other intangible assets | 845 | | All other current and non-current assets | 28 | | Accounts payable | (16) | | Contract liabilities | (34) | | Other current liabilities | (23) | | Deferred income taxes | (123) | | All other non-current liabilities(1) | (88) | | | | Total net assets post acquisition | $ | 2,293 | |
(1) All other non-current liabilities primarily includes tax reserves. The following table provides a summary of the purchase price consideration transferred for the acquisition of NMP. | | | | | | | Purchase consideration | Cash consideration, net of cash acquired | $ | 271 | | Fair value of previously held interest in NMP | 301 | | Fair value of contingent consideration | 5 | | Total allocable purchase price | $ | 577 | |
The fair values of the assets and liabilities assumed in connection with the acquisition of NMP, which were finalized in the first quarter of 2026 without material adjustment, are as follows. | | | | | | | Purchase price allocation | Receivables | $ | 53 | | Inventories | 9 | | All other current assets(1) | 35 | | Property, plant, and equipment | 239 | | Goodwill | 221 | | Other intangible assets | 235 | | All other non-current assets | 39 | | Deferred income taxes | (80) | | All other non-current liabilities | (145) | | Other(2) | (29) | | Total net assets post acquisition | $ | 577 | |
(1) All other current assets includes $35 million of indemnification assets, with the underlying indemnified liabilities recorded in All other non-current liabilities. (2) Other includes Accounts payable, All other current liabilities, and Current compensation and benefits.
|
| Schedule of Pro Forma Information |
Our unaudited supplemental pro forma consolidated financial information for the three and six months ended June 30, 2026 and 2025, including the results of operations for Intelerad as if the Intelerad acquisition had been completed on January 1, 2025, is as follows.
| | | | | | | | | | | | | | | | For the three months ended June 30 | For the six months ended June 30 | | 2026 | 2025 | 2026 | 2025 | Total revenues | $ | 5,295 | | $ | 5,065 | | $ | 10,478 | | $ | 9,898 | | Net income attributable to GE HealthCare | 567 | | 462 | | 971 | | 981 | |
|
| Schedule of Goodwill |
| | | | | | | | | | | | | | | | AIS | PDx | PCS | Total | | | | | | | | | | | | | | | | Balance at December 31, 2025 | $ | 8,702 | | $ | 2,745 | | $ | 2,041 | | $ | 13,489 | | Acquisitions(1) | 1,629 | | — | | — | | 1,629 | | Foreign currency exchange and other | (14) | | (7) | | (2) | | (23) | | Balance at June 30, 2026 | $ | 10,317 | | $ | 2,738 | | $ | 2,040 | | $ | 15,095 | |
(1) Includes the purchase of Intelerad recorded within our AIS segment, as described above.
|
| Schedule of Intangible Asset, Finite-Lived |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2026 | | As of December 31, 2025 | | Gross Carrying Amount | Accumulated Amortization | Net | | Gross Carrying Amount | Accumulated Amortization | Net | Definite-lived assets | | | | | | | | Customer-related | $ | 390 | | $ | (55) | | $ | 335 | | | $ | 279 | | $ | (43) | | $ | 236 | | Patents and technology | 3,379 | | (2,213) | | 1,167 | | | 2,698 | | (2,128) | | 570 | | Capitalized software | 1,769 | | (1,513) | | 256 | | | 1,703 | | (1,470) | | 233 | | Trademarks and other | 97 | | (35) | | 62 | | | 47 | | (31) | | 15 | | Total definite-lived assets | 5,635 | | (3,816) | | 1,820 | | | 4,727 | | (3,672) | | 1,055 | | Indefinite-lived assets(1) | 75 | | — | | 75 | | | 75 | | — | | 75 | | Total other intangible assets | $ | 5,710 | | $ | (3,816) | | $ | 1,894 | | | $ | 4,802 | | $ | (3,672) | | $ | 1,130 | |
(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.
|
| Schedule of Intangible Asset, Indefinite-Lived |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2026 | | As of December 31, 2025 | | Gross Carrying Amount | Accumulated Amortization | Net | | Gross Carrying Amount | Accumulated Amortization | Net | Definite-lived assets | | | | | | | | Customer-related | $ | 390 | | $ | (55) | | $ | 335 | | | $ | 279 | | $ | (43) | | $ | 236 | | Patents and technology | 3,379 | | (2,213) | | 1,167 | | | 2,698 | | (2,128) | | 570 | | Capitalized software | 1,769 | | (1,513) | | 256 | | | 1,703 | | (1,470) | | 233 | | Trademarks and other | 97 | | (35) | | 62 | | | 47 | | (31) | | 15 | | Total definite-lived assets | 5,635 | | (3,816) | | 1,820 | | | 4,727 | | (3,672) | | 1,055 | | Indefinite-lived assets(1) | 75 | | — | | 75 | | | 75 | | — | | 75 | | Total other intangible assets | $ | 5,710 | | $ | (3,816) | | $ | 1,894 | | | $ | 4,802 | | $ | (3,672) | | $ | 1,130 | |
(1) Indefinite-lived intangible assets relate to acquired in-process research and development prior to project completion and are not amortized.
|